FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2023890731> ?p ?o ?g. }

• W2023890731 endingPage "138" @default.
• W2023890731 startingPage "131" @default.
• W2023890731 abstract "Multiple myeloma is still uncurable. Myeloma cells become resistant to common drugs and patients eventually die of tumour progression. Therefore, new targets and drugs are urgently needed. NVP-BGT226 is a novel, orally bioavailable small-molecule inhibitor of phosphoinositol-3-kinase and mammalian target of rapamycin. Here, we show that NVP-BGT226 inhibits growth in common myeloma cell lines and primary myeloma cells at nanomolar concentrations in a time-dependent and dose-dependent manner. Western blots for the detection of caspase 3 cleavage and annexin-V–fluorescein isothiocyanate/propidium iodide assays revealed induction of apoptosis in common myeloma cells lines. Induction of apoptosis was accompanied by upregulation of proapoptotic Bim and a moderate upregulation of Mcl-1 and Bad and a downregulation of Bcl-2, Bax and Bcl-Xl. Inhibition of cell growth was mainly due to inhibition of myeloma cell proliferation, as shown by the 5-bromo-2′-deoxyuridine assay. Cell cycle analysis revealed induction of cell cycle arrest in the G1 phase, which was due to downregulation of cyclin D1, cyclin D2, pRb and cdc25a. NVP-BGT226 inhibited phosphorylation of protein kinase B (Akt), P70S6k and 4E-BP-1 in a time-dependent and dose-dependent manner. Furthermore, we show that the stimulatory effect of insulin-like growth factor 1, interleukin-6 and conditioned medium of HS-5 stromal cells on myeloma cell growth is completely abrogated by NVP-BGT226. Overall, inhibition of phosphoinositol-3-kinase/mammalian target of rapamycin by NVP-BGT226 is highly effective, and NVP-BGT226 represents a potential new candidate for targeted therapy in multiple myeloma." @default.
• W2023890731 created "2016-06-24" @default.
• W2023890731 creator A5001664010 @default.
• W2023890731 creator A5020263217 @default.
• W2023890731 creator A5050670093 @default.
• W2023890731 creator A5080040120 @default.
• W2023890731 creator A5082625244 @default.
• W2023890731 date "2012-01-01" @default.
• W2023890731 modified "2023-10-07" @default.
• W2023890731 title "Simultaneous targeting of PI3K and mTOR with NVP-BGT226 is highly effective in multiple myeloma" @default.
• W2023890731 cites W1949358987 @default.
• W2023890731 cites W1978505418 @default.
• W2023890731 cites W1995794901 @default.
• W2023890731 cites W1999198216 @default.
• W2023890731 cites W2007000374 @default.
• W2023890731 cites W2011282245 @default.
• W2023890731 cites W2013036515 @default.
• W2023890731 cites W2024884089 @default.
• W2023890731 cites W2039628288 @default.
• W2023890731 cites W2063355387 @default.
• W2023890731 cites W2063827408 @default.
• W2023890731 cites W2069159261 @default.
• W2023890731 cites W2082726173 @default.
• W2023890731 cites W2085868508 @default.
• W2023890731 cites W2087207416 @default.
• W2023890731 cites W2101880315 @default.
• W2023890731 cites W2109467838 @default.
• W2023890731 cites W2117043005 @default.
• W2023890731 cites W2118754985 @default.
• W2023890731 cites W2120473639 @default.
• W2023890731 cites W2144724291 @default.
• W2023890731 cites W2145529521 @default.
• W2023890731 cites W2152290005 @default.
• W2023890731 cites W2155009617 @default.
• W2023890731 cites W2316160054 @default.
• W2023890731 cites W2335120005 @default.
• W2023890731 cites W4236730981 @default.
• W2023890731 cites W4237659442 @default.
• W2023890731 cites W4376542883 @default.
• W2023890731 doi "https://doi.org/10.1097/cad.0b013e32834c8683" @default.
• W2023890731 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21959532" @default.
• W2023890731 hasPublicationYear "2012" @default.
• W2023890731 type Work @default.
• W2023890731 sameAs 2023890731 @default.
• W2023890731 citedByCount "43" @default.
• W2023890731 countsByYear W20238907312012 @default.
• W2023890731 countsByYear W20238907312013 @default.
• W2023890731 countsByYear W20238907312014 @default.
• W2023890731 countsByYear W20238907312015 @default.
• W2023890731 countsByYear W20238907312016 @default.
• W2023890731 countsByYear W20238907312017 @default.
• W2023890731 countsByYear W20238907312019 @default.
• W2023890731 countsByYear W20238907312020 @default.
• W2023890731 countsByYear W20238907312021 @default.
• W2023890731 countsByYear W20238907312022 @default.
• W2023890731 crossrefType "journal-article" @default.
• W2023890731 hasAuthorship W2023890731A5001664010 @default.
• W2023890731 hasAuthorship W2023890731A5020263217 @default.
• W2023890731 hasAuthorship W2023890731A5050670093 @default.
• W2023890731 hasAuthorship W2023890731A5080040120 @default.
• W2023890731 hasAuthorship W2023890731A5082625244 @default.
• W2023890731 hasConcept C104317684 @default.
• W2023890731 hasConcept C127561419 @default.
• W2023890731 hasConcept C153911025 @default.
• W2023890731 hasConcept C185592680 @default.
• W2023890731 hasConcept C190283241 @default.
• W2023890731 hasConcept C203014093 @default.
• W2023890731 hasConcept C2775934118 @default.
• W2023890731 hasConcept C2776364478 @default.
• W2023890731 hasConcept C2777478702 @default.
• W2023890731 hasConcept C29537977 @default.
• W2023890731 hasConcept C31573885 @default.
• W2023890731 hasConcept C502942594 @default.
• W2023890731 hasConcept C55493867 @default.
• W2023890731 hasConcept C62112901 @default.
• W2023890731 hasConcept C75217442 @default.
• W2023890731 hasConcept C86554907 @default.
• W2023890731 hasConcept C86803240 @default.
• W2023890731 hasConceptScore W2023890731C104317684 @default.
• W2023890731 hasConceptScore W2023890731C127561419 @default.
• W2023890731 hasConceptScore W2023890731C153911025 @default.
• W2023890731 hasConceptScore W2023890731C185592680 @default.
• W2023890731 hasConceptScore W2023890731C190283241 @default.
• W2023890731 hasConceptScore W2023890731C203014093 @default.
• W2023890731 hasConceptScore W2023890731C2775934118 @default.
• W2023890731 hasConceptScore W2023890731C2776364478 @default.
• W2023890731 hasConceptScore W2023890731C2777478702 @default.
• W2023890731 hasConceptScore W2023890731C29537977 @default.
• W2023890731 hasConceptScore W2023890731C31573885 @default.
• W2023890731 hasConceptScore W2023890731C502942594 @default.
• W2023890731 hasConceptScore W2023890731C55493867 @default.
• W2023890731 hasConceptScore W2023890731C62112901 @default.
• W2023890731 hasConceptScore W2023890731C75217442 @default.
• W2023890731 hasConceptScore W2023890731C86554907 @default.
• W2023890731 hasConceptScore W2023890731C86803240 @default.
• W2023890731 hasIssue "1" @default.
• W2023890731 hasLocation W20238907311 @default.
• W2023890731 hasLocation W20238907312 @default.

• next